Effect of fluticasone propionate aqueous nasal spray on allergen- induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide

Clinical and Experimental Allergy

Volumn 29, Issue 2, 1999, Pages 234-240

  Wang, J H ^a   Devalia, J L ^a   Rusznak, C ^a   Bagnall, A ^a   Sapsford, R J ^a   Davies, R J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Allergic rhinitis; Eosinophil cationic protein; Eosinophils; Fluticasone propionate; Nitrogen dioxide

Indexed keywords

ALLERGEN; BECLOMETASONE DIPROPIONATE; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE PROPIONATE; HYDROCORTISONE; NITROGEN DIOXIDE;

ADULT; AIR POLLUTION; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT SENSITIZATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; EOSINOPHILIA; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NOSE AIRWAY RESISTANCE; NOSE PROVOCATION TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; ALLERGENS; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; BLOOD PROTEINS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; NASAL MUCOSA; NASAL PROVOCATION TESTS; NEBULIZERS AND VAPORIZERS; NITROGEN DIOXIDE; RHINITIS, ALLERGIC, SEASONAL; RIBONUCLEASES;

EID: 0033008297     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00440.x     Document Type: Article

References (19)

1. 1 Department of Health Advisory Group on the Medical Aspects of Air Pollution Episodes First Report - Ozone London: HMSO, 1991.
2. 2 Department of Health Advisory Group on the Medical Aspects of Air Pollution Episodes Second Report - Sulphur dioxide, acidaerosols. particulates. London: HMSO, 1992.
3. 3 Department of Health Advisory Group on the Medical Aspects of Air Pollution Episodes Third Report - Oxides of nitrogen. London: HMSO, 1993.
4. 4 Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. Br Med J 1992; 304:873-5.
5. 5 Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989; 19:59-63.
6. 6 Ishizaki T, Koizumi K, Ikemori R, Ishiyama Y, Kushibiki E. Studies of prevalence of Japanese cedar pollinosis among residents in a densely cultivated area. Ann Allergy 1987; 58:265.
7. 7 von Mutius E, Fritzsch C, Weiland SK, Roll G, Magnussen H. Prevalence of asthma and allergic disorders among children in united Germany. Br Med J 1992; 305:1395.
8. 8 Tunnicliffe WS, Burge PS, Ayres JG. Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients. Lancet 1994; 344:1733-6.
9. 9 Devalia JL, Rusznak C, Herdman MJ et al. Effect of nitrogen dioxide and sulphur dioxide on airway response of mild asthmatic patients to allergen inhalation. Lancet 1994; 344:1668-71.
10. 2) on early phase nasal response to allergen challenge in patient with a history of seasonal allergic rhinitis. J Allergy Clin Immunol 1995; 96:669-76.
11. 11 Peden DB, Carter J, Dailey LA, Devlin R. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am J Respir Crit Care Med 1995; 151:1336-45.
12. 12 Fuller R, Johnson M, Bye A. Fluticasone propionate: an update on preclinical and clinical experience. Respir Med 1995; 89 (Suppl.):A):3-18.
13. 13 Lozewicz S, Wang JH, Duddle J et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992; 89:951-7.
14. 14 Rak S, Jacobson MR, Sudderick RM et al. Influence of prolonged treatment with topical corticosteroids (fluticasone propionate) on early and late phase response and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exper Allergy 1994; 24:930-9.
15. 15 Robinson DS, Durham SR, Kay AB. Cytokines in asthma. Thorax 1993; 48:845-53.
16. 16 Weido AJ, Reece LM, Alam R, Cook CK, Sim TC. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Ann Allergy Asthma Immunol 1996; 77:407-15.
17. 17 Wang JH, Trigg CJ, Devalia JL, Jordan S, Davies RJ. Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma. J Allergy Clin Immunol 1994; 94:1025-34.
18. 18 Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996; 14:27-35.
19. 19 Wang JH, Devalia JL, Sapsford RJ, Davies RJ. Effect of corticosteroids on release of RANTES and sICAM-1 from cultured human bronchial epithelial cells, induced by TNF-α. Eur Respir J 1997; 10:834-40.